In an interview with Pharmacy Times, Caitlin Jones, PhD, discusses why high-risk, low-benefit treatments for chronic low back pain require greater scrutiny.
Caitlin Jones, PHD
Advertisement
Articles by Caitlin Jones, PHD
Pharmacy Times speaks with Caitlin Jones, PHD, on opioids, spinal cord stimulators, and treatment-related harms in chronic low back pain.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
2
The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline
3
Study Reveals a Widening Gap Between Buprenorphine Prescribing and Dispensing
4
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
5